Skip to content

Christopher P. Albertyn

3 papers in the library · 1 citation · publishing 2025-2026

Papers

Sort Most recent Most cited

Mapping Psychedelic-Assisted Therapy Facilitator Education and Training Programs Internationally: A Scoping Review

2026 Juliana Mendes Rocha, Elisabeth Tove Irving, Evan Forth et al. preprint

Introduction Psychedelic assisted therapy has gained increasing clinical and research attention in the last decade due to its demonstrated therapeutic potential across a variety of complex and treatment-resistant psychiatric and psychosocial conditions. As interest grows, so has the development of facilitator education and training programs. Despite this proliferation, concerns remain regarding...

The CAnadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT): A Multi-Phase Program Overview.

Current Oncology December 22, 2025 Linda E. Carlson, Harriet Richardson, Ron Shore et al. 1 citation

The CAnadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT) was launched in 2025 to address urgent gaps in supportive care for Canadians with cancer experiencing demoralization syndrome (loss of meaning, dysphoria, disheartenment, helplessness, a sense of failure) and related psychosocial distress. CAN-PACT has six major objectives: (1) to develop a national interdisciplinary...

Mindfulness-Based Psilocybin-Assisted Therapy (MB-PAT) for cancer-related demoralization in Canada: the case for a hybrid group-based delivery model

Christopher P. Albertyn, Jérémie Richard, Ron Joseph Shore et al. preprint

Demoralization syndrome (DS) - a distinct clinical entity characterized by helplessness, hopelessness, and a persistent loss of meaning - affects approximately one in five Canadians with advanced cancer and is associated with increased desire for hastened death, negative clinical outcomes, and higher economic burden, yet recognition and treatment of DS remains suboptimal in modern oncology....